Abstract
Four patients with advanced or metastatic bladder cancer progressing after MVAC chemotherapy were treated with oral piritrexim. Three of the four patients were evaluable for response, and all three had a partial response to treatment. Piritrexim may be an effective drug for bladder cancer after progression on MVAC chemotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | 448-451 |
| Number of pages | 4 |
| Journal | American Journal of Clinical Oncology: Cancer Clinical Trials |
| Volume | 17 |
| Issue number | 5 |
| State | Published - Jan 1 1994 |
Fingerprint
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Oral piritrexim in advanced bladder cancer : An effective drug after progression on MVAC chemotherapy? / Feun, Lynn G; Savaraj, Niramol; Benedetto, Pasquale W; Waldman, S.; Collier, M.; Clendennin, N. J.
In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 17, No. 5, 01.01.1994, p. 448-451.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Oral piritrexim in advanced bladder cancer
T2 - An effective drug after progression on MVAC chemotherapy?
AU - Feun, Lynn G
AU - Savaraj, Niramol
AU - Benedetto, Pasquale W
AU - Waldman, S.
AU - Collier, M.
AU - Clendennin, N. J.
PY - 1994/1/1
Y1 - 1994/1/1
N2 - Four patients with advanced or metastatic bladder cancer progressing after MVAC chemotherapy were treated with oral piritrexim. Three of the four patients were evaluable for response, and all three had a partial response to treatment. Piritrexim may be an effective drug for bladder cancer after progression on MVAC chemotherapy.
AB - Four patients with advanced or metastatic bladder cancer progressing after MVAC chemotherapy were treated with oral piritrexim. Three of the four patients were evaluable for response, and all three had a partial response to treatment. Piritrexim may be an effective drug for bladder cancer after progression on MVAC chemotherapy.
UR - http://www.scopus.com/inward/record.url?scp=0028041356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028041356&partnerID=8YFLogxK
M3 - Article
VL - 17
SP - 448
EP - 451
JO - American Journal of Clinical Oncology
JF - American Journal of Clinical Oncology
SN - 0277-3732
IS - 5
ER -